APA

de Steenwinkel J. E. M., ten Kate M. T., de Knegt G. J., Verbrugh H. A., Aarnoutse R. E., Boeree M. J., den Bakker M. A., van Soolingen D. & Bakker-Woudenberg I. A. J. M. (20130107). Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. : Antimicrobial agents and chemotherapy.

Chicago

de Steenwinkel Jurriaan E M, ten Kate Marian T, de Knegt Gerjo J, Verbrugh Henri A, Aarnoutse Rob E, Boeree Martin J, den Bakker Michael A, van Soolingen Dick and Bakker-Woudenberg Irma A J M. 20130107. Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. : Antimicrobial agents and chemotherapy.

Harvard

de Steenwinkel J. E. M., ten Kate M. T., de Knegt G. J., Verbrugh H. A., Aarnoutse R. E., Boeree M. J., den Bakker M. A., van Soolingen D. and Bakker-Woudenberg I. A. J. M. (20130107). Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. : Antimicrobial agents and chemotherapy.

MLA

de Steenwinkel Jurriaan E M, ten Kate Marian T, de Knegt Gerjo J, Verbrugh Henri A, Aarnoutse Rob E, Boeree Martin J, den Bakker Michael A, van Soolingen Dick and Bakker-Woudenberg Irma A J M. Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis. : Antimicrobial agents and chemotherapy. 20130107.